Close Menu
    Facebook LinkedIn YouTube WhatsApp X (Twitter) Pinterest
    Trending
    • Robot wins half marathon faster than human record
    • Analysis of 200 education dept-endorsed school apps finds most are selling BS when it comes to the privacy of children’s data
    • Spoofed Tankers Are Flooding the Strait of Hormuz. These Analysts Are Tracking Them
    • Polymarket is in talks to raise $400M at a ~$15B post-money valuation, up from $9B in October 2025, but below Kalshi’s $22B valuation from March 2026 (The Information)
    • Today’s NYT Connections: Sports Edition Hints, Answers for April 20 #574
    • Will Humans Live Forever? AI Races to Defeat Aging
    • AI evolves itself to speed up scientific discovery
    • Australia’s privacy commissioner tried, in vain, to sound the alarm on data protection during the u16s social media ban trials
    Facebook LinkedIn WhatsApp
    Times FeaturedTimes Featured
    Monday, April 20
    • Home
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    • More
      • AI
      • Robotics
      • Industries
      • Global
    Times FeaturedTimes Featured
    Home»Tech Innovation»Zeaxanthin boosts immune cells in cancer treatment
    Tech Innovation

    Zeaxanthin boosts immune cells in cancer treatment

    Editor Times FeaturedBy Editor Times FeaturedSeptember 3, 2025No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email WhatsApp Copy Link


    A carotenoid that is already extensively accessible in fruit and greens, and as a complement, has been discovered to bolster the cancer-fighting talents of immune cells, making it a promising new candidate that would assist shrink tumors throughout immunotherapy therapy.

    Following years of labor investigating pure compounds to boost most cancers therapies, researchers from the College of Chicago have found that zeaxanthin – a carotenoid that promotes eye well being – boosts the exercise of the immune system’s CD8+ T cells, which search and destroy cancerous tumor cells.

    “We had been stunned to search out that zeaxanthin, already identified for its function in eye well being, has a very new operate in boosting anti-tumor immunity,” mentioned senior writer Jing Chen, Professor of Drugs on the College of Chicago. “Our research present {that a} easy dietary nutrient may complement and strengthen superior most cancers therapies like immunotherapy.”

    Screening a big blood nutrient library – the vary of vitamins measured in blood exams – the researchers discovered that zeaxanthin stabilizes and strengthens the formation of T-cell receptor (TCR) constructions on CD8+ T cells when the immune cells encounter most cancers growths. This then prompts stronger signaling inside cells, enhancing T-cell activation, cytokine manufacturing and tumor-killing talents. Mainly, it equips the immune cells with what they should mount a fiercer struggle.

    In mouse fashions, animals given a food plan excessive in zeaxanthin exhibited considerably slower tumor progress. When mixed with immune checkpoint inhibitors – the breakthrough immunotherapy that stops the immune system from attacking wholesome cells – the T cells’ tumor-fighting capability was additional enhanced. When examined on human T cells, which had been developed to acknowledge a spread of tumor antigens, zeaxanthin bolstered the immune cells’ energy in killing off melanoma, a number of myeloma and glioblastoma cells.

    “Our information present that zeaxanthin improves each pure and engineered T-cell responses, which suggests excessive translational potential for sufferers present process immunotherapies,” Chen mentioned.

    Zeaxanthin is a sort of xanthophyll – a yellow carotenoid pigment discovered broadly in nature – already accessible as a complement for eye well being, and located in darkish leafy greens like kale, in addition to orange peppers, mango and corn. And since zeaxanthin has a well known security profile, it might be simply integrated into present most cancers immunotherapy therapy regimens.

    Whereas scientific trials will likely be required to see if the constructive outcomes from the lab and mice research will be replicated in most cancers sufferers, zeaxanthin is a promising new avenue of analysis geared toward making immunotherapy extra profitable. Earlier research have discovered {that a} vary of pure compounds – like these present in licorice and beans – can probably enhance the physique’s response to most cancers cells.

    “Our findings open a brand new area of dietary immunology that appears at how particular dietary parts work together with the immune system on the molecular degree,” Chen mentioned. “With extra analysis, we might uncover pure compounds that make at present’s most cancers therapies simpler and accessible.”

    The analysis was printed within the journal Cell Reports Medicine.

    Supply: University of Chicago





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Editor Times Featured
    • Website

    Related Posts

    Robot wins half marathon faster than human record

    April 20, 2026

    AI evolves itself to speed up scientific discovery

    April 20, 2026

    AI Machine-Vision Earns Man Overboard Certification

    April 20, 2026

    Scandi-style tiny house combines smart storage and simple layout

    April 19, 2026

    OneOdio Focus A1 Pro review

    April 19, 2026

    Sulfur lava exoplanet L 98-59 d defies classification

    April 19, 2026

    Comments are closed.

    Editors Picks

    Robot wins half marathon faster than human record

    April 20, 2026

    Analysis of 200 education dept-endorsed school apps finds most are selling BS when it comes to the privacy of children’s data

    April 20, 2026

    Spoofed Tankers Are Flooding the Strait of Hormuz. These Analysts Are Tracking Them

    April 20, 2026

    Polymarket is in talks to raise $400M at a ~$15B post-money valuation, up from $9B in October 2025, but below Kalshi’s $22B valuation from March 2026 (The Information)

    April 20, 2026
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    About Us
    About Us

    Welcome to Times Featured, an AI-driven entrepreneurship growth engine that is transforming the future of work, bridging the digital divide and encouraging younger community inclusion in the 4th Industrial Revolution, and nurturing new market leaders.

    Empowering the growth of profiles, leaders, entrepreneurs businesses, and startups on international landscape.

    Asia-Middle East-Europe-North America-Australia-Africa

    Facebook LinkedIn WhatsApp
    Featured Picks

    A crackdown on plane cabin baggage is coming – here’s what you need to know from an ex-pilot

    January 13, 2026

    Exciting Changes Are Coming to the TDS Author Payment Program

    March 2, 2026

    Today’s NYT Mini Crossword Answers for Feb. 17

    February 17, 2026
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    Copyright © 2024 Timesfeatured.com IP Limited. All Rights.
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us

    Type above and press Enter to search. Press Esc to cancel.